Auditing Clinical Outcomes after Introducing Off-Licence Prescribing of Atypical Antipsychotic Melperone for Patients with Treatment Refractory Schizophrenia

Table 3

Those 4 patients who stopped Melperone as it is considered “ineffective.”

Age	Sex	Race	Duration illness/number of previous hospitalisations	Duration of treatment	Max. dose reached	Baseline BPRS	Followup BPRS (time since baseline test)
51	M	Asian	20/3	13 months	400 mg	62	63 (6 months)
35	M	Black African	15/4	4 months	600 mg	48	54 (7 weeks)
51	M	White Cauc.	25/5	<1 month	200 mg	Not assessed	Not assessed
49	F	Asian	10/3	<1 month	300 mg	78	75 (3 weeks)